Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-19
1989-09-05
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514366, A61K 3144, A61K 31425
Patent
active
048639303
ABSTRACT:
5H-pyrido[2',1':2,3]imidazo[4,5-b]indoles of the formulae ##STR1## their pharmaceutically acceptable acid addition salts and the corresponding compounds bearing one or more halogens and/or lower-alkyl groups on the available ring carbon atoms are administered in cholinomimetic amounts to mammals with low acetylcholine or cholinergic activity to ameliorate the symptoms associated with that condition.
REFERENCES:
K. L. Davis et al., Cholinergic Drugs in Alzheimer's Disease, Editorials, The New England J. of Med., vol. 315, No. 20, pp. 1286-1287 (1986).
J. H. Growdon et al., Neurochemical Approaches to the Treatment of Senile Dementia, Psychopathology in the Aged, pp. 281-294 (1980).
P. Davies, Theoretical Treatment Posibilities for Dementia of the Alzheimer Type: The Cholinergic Hypythesis, Theoretical Treatment Strategies for the Development of an Effective Treatment for Senile Dementia, pp. 19-32 (1981).
Kearse Richard
Robinson Douglas W.
LandOfFree
Use of substituted 5H-pyrido- and 5H-thiazolo(2',1':2,3)imidazo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of substituted 5H-pyrido- and 5H-thiazolo(2',1':2,3)imidazo , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of substituted 5H-pyrido- and 5H-thiazolo(2',1':2,3)imidazo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-243673